InsiderClue
← All stocks

Coherus Oncology, Inc.

CHRS Net selling
CIK 0001512762 #3931 in the set updated 22 Sep 2026
Bought (120 mo)
$49.67K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$66.47M
$0.00 on a plan · $11.67M straight out of an exercise
Sold at will
$54.81M
44 of 107 sales
Net
−$66.43M
−$54.76M against sales at will

By person

21 insiders · 117 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
HEALY JAMES
Director
—
$27.90M (8)
−$27.90M
504,641
0.3266%
$372.88K
−84.8%
Lanfear Dennis M
President & CEO
—
$16.93M (6)
−$16.93M
2,014,568
1.30%
$1.49M
+3.7%
Wahlstrom Mats
Director
—
$7.35M (6)
−$7.35M
30,000
0.0194%
$22.17K
−95.3%
Anicetti Vincent R
Chief Operating Officer
—
$4.44M (33) scheduled
−$4.44M
124,790
0.0808%
$92.21K
+992.3%
Vexler Vladimir
Chief Scientific Officer
—
$3.08M (3) scheduled
−$3.08M
116,361
0.0753%
$85.98K
+716.3%
Viret Jean-Frederic
Chief Financial Officer
—
$2.85M (29) scheduled
−$2.85M
61,295
0.0397%
$45.29K
+507.8%
Herman Alan C.
Chief Scientific Officer
—
$2.78M (15)
−$2.78M
350,624
0.2269%
$259.08K
−25.4%
Szela Mary T
Director
—
$966.76K (1) scheduled
−$966.76K
0
0.0000%
$0.00
—
FINCK BARBARA K
Chief Medical Officer
—
$118.99K (5) scheduled
−$118.99K
37,043
0.0240%
$27.37K
+25.6%
Stilwell McDavid
Chief Financial Officer
$49.67K (1)
$58.92K (1)
−$9.25K
75,305
0.0487%
$55.64K
+1,175%
Troendle August J.
Director
—
—
—
298,422
0.1932%
$220.50K
0.0%
McMichael Bryan J
Chief Financial Officer
—
—
—
133,736
0.0866%
$98.82K
+604.4%
Reider Paul
Chief Commercial Officer
—
—
—
82,069
0.0531%
$60.64K
−20.2%
Richards Christos
Director
—
—
—
63,836
0.0413%
$47.17K
0.0%
Satvat Ali J.
Director
—
—
—
30,000
0.0194%
$22.17K
—
Newton Charles W.
Director
—
—
—
30,000
0.0194%
$22.17K
—
Newcomer Lee Nisley
Director
—
—
—
30,000
0.0194%
$22.17K
—
Karachun Rita A
Director
—
—
—
30,000
0.0194%
$22.17K
—
Ryan Michael Lee
Director
—
—
—
30,000
0.0194%
$22.17K
—
O'Donnell-Tormey Jill
Director
—
—
—
30,000
0.0194%
$22.17K
—
Watler Peter K.
Chief Technical Officer
—
—
—
5,900
0.0038%
$4.36K
—

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
Wahlstrom Mats
23 May 2025
Director
Sell indirect
99,988
$0.74
$73.88K
Stilwell McDavid
15 Oct 2021
Chief Financial Officer
Sell
3,507
$16.80
$58.92K
HEALY JAMES
29 Sep 2021
Director
Sell indirect
286,076
$16.12
$4.61M
HEALY JAMES
28 Sep 2021
Director
Sell indirect
48,329
$17.17
$829.81K
HEALY JAMES
27 Sep 2021
Director
Sell indirect
100,150
$18.06
$1.81M
Viret Jean-Frederic
14 Oct 2020
Chief Financial Officer
Sell
6,144
$19.00
$116.74K
Wahlstrom Mats
17 Jun 2020
Director
Sell indirect
200,000
$17.15
$3.43M
Viret Jean-Frederic
20 May 2020
Chief Financial Officer
Sell
1,278
$17.66
$22.57K
Anicetti Vincent R
20 Apr 2020
Chief Operating Officer
Sell
5,150
$17.00
$87.55K
Wahlstrom Mats
3 Mar 2020
Director
Sell indirect
4,222
$20.89
$88.21K
Wahlstrom Mats
3 Mar 2020
Director
Sell indirect
113,844
$20.09
$2.29M
Lanfear Dennis M
21 Nov 2019
President & CEO
Sell indirect
12,500
$18.56
$231.96K
Lanfear Dennis M
20 Nov 2019
President & CEO
Sell indirect
825,000
$18.00
$14.85M
Viret Jean-Frederic
18 Nov 2019
Chief Financial Officer
Sell
3,112
$18.88
$58.76K
Viret Jean-Frederic
18 Oct 2019
Chief Financial Officer
Sell
1,388
$19.02
$26.40K
Viret Jean-Frederic
23 Sep 2019
Chief Financial Officer
Sell
740
$21.78
$16.12K
Viret Jean-Frederic
19 Aug 2019
Chief Financial Officer
Sell
3,000
$19.04
$57.12K
HEALY JAMES
2 Jul 2019
Director
Sell indirect
160,000
$22.61
$3.62M
HEALY JAMES
28 Jun 2019
Director
Sell indirect
200,000
$22.05
$4.41M
HEALY JAMES
20 Jun 2019
Director
Sell indirect
317,130
$21.37
$6.78M
Viret Jean-Frederic
18 Jun 2019
Chief Financial Officer
Sell
3,000
$19.31
$57.93K
Lanfear Dennis M
30 May 2019
President & CEO
Sell indirect
32,398
$19.49
$631.28K
HEALY JAMES
22 May 2019
Director
Sell indirect
257,870
$20.69
$5.34M
Viret Jean-Frederic
20 Mar 2019
Chief Financial Officer
Sell
3,000
$14.92
$44.76K
HEALY JAMES
29 Aug 2018
Director
Sell indirect
25,000
$20.50
$512.50K
Viret Jean-Frederic
23 Jul 2018
Chief Financial Officer
Sell
9,291
$18.56
$172.47K
Lanfear Dennis M
16 May 2018
See Remarks
Sell indirect
20,984
$16.26
$341.26K
Herman Alan C.
8 Aug 2017
Chief Scientific Officer
Sell
17,535
$15.02
$263.30K
Herman Alan C.
5 Jul 2017
Chief Scientific Officer
Sell
600
$15.00
$9.00K
Herman Alan C.
1 Jun 2017
Chief Scientific Officer
Sell
1,732
$20.98
$36.34K
Herman Alan C.
1 Jun 2017
Chief Scientific Officer
Sell
9,601
$20.20
$193.95K
Herman Alan C.
1 May 2017
Chief Scientific Officer
Sell
11,333
$20.00
$226.63K
Herman Alan C.
3 Apr 2017
Chief Scientific Officer
Sell
11,333
$20.73
$234.99K
Herman Alan C.
1 Mar 2017
Chief Scientific Officer
Sell
11,333
$24.19
$274.17K
Herman Alan C.
1 Feb 2017
Chief Scientific Officer
Sell
11,333
$27.37
$310.15K
Herman Alan C.
3 Jan 2017
Chief Scientific Officer
Sell
683
$28.60
$19.54K
Herman Alan C.
3 Jan 2017
Chief Scientific Officer
Sell
10,650
$27.90
$297.19K
Wahlstrom Mats
8 Dec 2016
Director
Sell indirect
46,190
$27.52
$1.27M
Wahlstrom Mats
7 Dec 2016
Director
Sell indirect
7,393
$27.50
$203.33K
Herman Alan C.
1 Dec 2016
Chief Scientific Officer
Sell
8,133
$27.55
$224.08K
Herman Alan C.
1 Dec 2016
Chief Scientific Officer
Sell
3,200
$27.01
$86.45K
Herman Alan C.
1 Nov 2016
Chief Scientific Officer
Sell
11,333
$27.53
$312.04K
Herman Alan C.
3 Oct 2016
Chief Scientific Officer
Sell
3,237
$26.26
$85.00K
Herman Alan C.
3 Oct 2016
Chief Scientific Officer
Sell
8,096
$25.47
$206.20K
Show all 117 transactions →

What was left out

Form 4 filings counted 263
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 63
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 6,673,645
Sales filed before the plan box existed 43
History held since 6 Sep 2016